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Abstract
The Steroid Receptor RNA Activator (SRA) enhances adipogenesis and increases both glucose uptake and phosphorylation
of Akt and FOXO1 in response to insulin. To assess the mechanism, we differentiated ST2 mesenchymal precursor cells that
did or did not overexpress SRA into adipocytes using combinations of methylisobutylxanthine, dexamethasone and insulin.
These studies showed that SRA overexpression promotes full adipogenesis in part by stimulation of insulin/insulin-like
growth factor-1 (IGF-1) signaling. SRA overexpression inhibited phosphorylation of p38 mitogen activated protein kinase
(MAPK) and c-Jun NH2-terminal kinase (JNK) in the early differentiation of ST2 cells. Conversely, knockdown of endogenous
SRA in 3T3-L1 cells increased phosphorylation of JNK. Knockdown of SRA in mature 3T3-L1 adipocytes reduced insulin
receptor (IR) mRNA and protein levels, which led to decreased autophosphorylation of IRb and decreased phosphorylation
of insulin receptor substrate-1 (IRS-1) and Akt. This likely reflects a stimulatory role of SRA on IR transcription, as transfection
studies showed that SRA increased expression of an IR promoter-luciferase reporter construct.
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Introduction
Obesity is closely associated with a number of diseases including
type 2 diabetes, cardiovascular disease, hypertension, cancer and
gallstones. Adipocytes function both as reservoirs of fuel and as
endocrine cells, secreting adipokines such as leptin, adiponectin,
interleukin-6 and tumor necrosis factor-a to regulate whole-body
energy metabolism and glucose homeostasis [1,2]. Adipogenesis is
a complex process that is highly regulated by coordinated effects of
numerous transcription factors and signaling molecules, including
peroxisome proliferator-activated receptor gamma (PPARc) [3,4],
the CCAAT/enhancer-binding proteins (C/EBPs) [5,6], Kruppel-
like factors (KLFs) [7], Wingless proteins (Wnts) [8], and E2Fs [9].
Both 3T3-L1 preadipocytes and bone marrow-derived ST2
adipocyte precursors can be differentiated in cell culture into
mature adipocytes by standard hormone cocktails that include
fetal bovine serum (FBS), 3-isobutyl-1-methylxanthine (IBMX),
dexamethasone (Dex) and insulin [10,11]. IBMX and Dex are
important for preadipocyte differentiation, whereas insulin plays
unique and important roles in both adipocyte differentiation and
mature adipocyte function. Insulin is postulated to regulate
adipogenesis by activating extracellular signal-regulated kinase
(ERK) and p38 kinase [5,12], and/or critical signaling compo-
nents such as insulin receptor substrate-1 (IRS-1) [13,14], Akt
[15,16] and mTOR [17]. However, the molecular mechanisms
through which insulin promotes adipogenesis are not fully
understood.
After terminal differentiation, adipocytes in culture increase
lipogenesis and gain sensitivity to insulin through expression of
proteins such as PPARc, C/EBPa, adiponectin, Glut4, insulin
receptor (IR) and IRS-1. Insulin stimulates glucose uptake,
utilization and storage through binding to the IR, which triggers
autophosphorylation of the IR b-subunit [18], activation of IRS-1
by tyrosine phosphorylation, and activation of downstream
signaling through the phosphatidylinositol 3-kinase (PI3K)-Akt/
protein kinase B, Ras-mitogen-activated protein kinase (MAPK),
and Cbl-CAP pathways [18,19,20]. Given the central role of the
IR, it is important to note that the hyperinsulinemia accompany-
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ing insulin-resistant states such as obesity and type 2 diabetes can
be associated with lowered IR levels [21,22,23].
The Sra1 gene expresses a steroid receptor RNA activator (SRA)
that was initially found to be a transcriptional coactivator for
steroid receptors [24]. It has subsequently been found to serve as a
coactivator for numerous transcription factors [25,26,27,28], but
the biological functions of SRA are largely unknown. We have
recently shown that SRA functions as a coactivator of PPARc and
promotes adipocyte differentiation [29]. Our gene profiling
experiments revealed hundreds of SRA-responsive genes in
adipocytes, but the molecular mechanisms by which SRA
enhances adipogenesis and insulin-stimulated glucose uptake
remain to be elucidated. By alternative splicing, Sra1 also encodes
an SRA protein (SRAP) [30,31], although the function of SRAP is
largely unknown. In this study, we report that SRA regulates
signaling events early in preadipocyte differentiation. In mature
adipocytes SRA increases insulin receptor (IR) transcription and
IR protein content, which results in increased insulin-responsive
phosphorylation of the IR and downstream targets such as IRS-1
and Akt.
Materials and Methods
Cell Culture, Staining and Reagents
Mouse 3T3-L1 preadipocytes and human embryonic kidney
293T cells were obtained from the American Type Culture
Collection (ATCC) and maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% calf serum and
penicillin-streptomycin at 37uC in 10% CO2. Mouse marrow-
derived ST2 cells were obtained from the Riken Bioresource
Center-Cell Bank and incubated at 37uC in 5% CO2 in a-minimal
essential medium supplemented with 10% FBS and penicillin-
streptomycin. Induction of 3T3-L1 or ST2 cell differentiation was
performed as described [29]. Briefly, 2 day post-confluent cells
(day 0) were fed with media supplemented with 10% FBS and a
hormone cocktail containing IBMX (0.5 mM), dexamethasone
(1 mM) and insulin (0.167 mM), denoted MDI. On day 2, the cells
were treated again with 0.167 mM insulin, and subsequently were
refed with growth media containing 10% FBS every 2 days. In
some studies, troglitazone (50 mM in dimethylsulfoxide) was
added to the hormone cocktail to achieve a final media
concentration of 5 mM (MDIT). Lipid accumulation in adipocytes
was visualized by micrographs or staining with Oil Red O as
described previously [29].
Antibodies against the following proteins were obtained as
indicated: SRAP (Cat# A310-226A, Bethyl Laboratories, Mon-
tgomery, TX); Phospho-p38 MAPK (Thr180/Tyr182) (3D7)
(Cat# 9215), Phospho-p44/42 MAPK (thr202/Tyr204)
(D13.14.4E) (Cat# 4370), p38 MAPK (Cat# 9212), p44/42
MAPK (137F5) (Cat# 4695), Insulin Receptor b (4B8) (Cat#
3025), IRS-1 (Cat# 2382), phospho-SAPK/JNK (Thr183/
Tyr185) (81E11) (Cat# #4668), SAPK/JNK (56G8) (Cat#
9258), JNK1 (2C6) (Cat# 3708), JNK2 (Cat# 4672), JNK3
(55A8) (Cat# 2305), b-actin (Cat# 4967), Phospho-Insulin
Receptor b (PY1345) (Cat# 3026), Phospho-Insulin Receptor b
(PY1361) (Cat# 3023), Phospho-Akt (Thr308) (Cat# 9275) and
Akt (Cat# 9272) from Cell Signaling Technology (Danvers, MA);
Phospho-Insulin Receptor b (pY972), Phospho-IRS-1 (pY941) and
Phospho-IRS-1 (pY612) from Invitrogen (Carlsbad, CA); Phos-
pho-Insulin Receptor b (pY1328) from BioSource (Camarillo,
CA); and phosphotyrosine (pY4G10) from Millipore (Cat# 05-
321) (Billerica, MA).
Gene Silencing by Short Hairpin RNA (shRNA)
A 21-nucleotide shRNA construct targeting mouse SRA1
mRNA was cloned into the retroviral pSUPERIOR.retro.puro
vector (OligoEngine (Seattle, WA)) or the pLentiLox3.7-GFP
vector with a sense-loop-antisense design, using the loop sequence
CTTCCTGTCA as described [29].
Plasmids, Transfection and Retroviral Infection
The human SRA isoform 2 expression vector pSCT-SRA (non-
protein coding) was kindly provided by Dr. Rainer Lanz (Baylor
College of Medicine, Houston, TX) [24]. The pMSCV retroviral
expression vector and pMSCV-SRA were described previously
[29,32]. Retroviral transduction of ST2 or 3T3-L1 cells for stable
overexpression of pMSCV/pMSCV-SRA or knockdown of
endogenous SRA by either retroviral or lentiviral transduction of
shRNA against SRA and shControl was performed as described
previously [29]. The plasmid pSCT-SRA (denoted SRA Only),
contains the human SRA RNA core sequence and hence expresses
SRA but not SRAP. By alternative splicing the SRA1 gene also can
encode a protein, SRAP [31,33]. Human full-length SRAP cDNA
(hSRAP) was amplified by PCR using cDNA template that was
reverse transcribed from total RNA of HepG2 cells. The amplified
hSRAP cDNA with Sal1 and Kpn1 overhangs was ligated into the
pSCT vector to derive pSCT-hSRAP (denoted SRA-WT). pSCT-
hSRAP expresses both the full length SRA RNA and SRAP.
SRAP mutations including a point mutation and a series of silent
mutations in SRA RNA stem loops 1 and 7 were constructed by
inverse PCR and are described later. The introduction of silent
nucleotide mutations in the SRA stem loops 1 and 7 which
disrupted the RNA stem loop structure and impaired its
coactivation was described previously [34]. pGluc-Basic contain-
ing a reporter gene but lacking promoter elements was obtained
from the New England BioLabs. pIRP-GLuc, in which the insulin
receptor promoter (21718 to +106 bp relative to the most 59
transcription start site) drives expression of Gaussia Luciferase, was
a gift from Drs. R. Singh and A. Mani (Yale University School of
Medicine, New Haven, CT) [35]. Transient transfections were
performed as described previously [27].
Cell Lysis and Immunoblotting
Cells were lysed in buffer containing 40 mM HEPES, 120 mM
sodium chloride, 10 mM sodium pyrophosphate, 10 mM sodium
glycerophosphate, 1 mM EDTA, 50 mM sodium fluoride,
0.5 mM sodium orthovanadate and 1% Triton X-100. Cell lysates
were gently resuspended and incubated at 4uC with gentle rocking
for 40 min to 1 h, followed by microcentrifugation for 10 min at
4uC. The supernatants were transferred to new tubes and protein
concentrations were determined. Proteins were separated by SDS-
PAGE and transferred onto polyvinylidene difluoride membranes,
and immunoblotting was performed using the antibodies described
above. Detection by enhanced chemiluminescence was with a
SuperSignal West Dura kit (Thermo Fisher Scientific, Rockford,
IL) and a Bio-Rad Fluor-S Max Multi-Imager.
Gene Expression Analysis
For reverse transcription-real time quantitative PCR (RT-
qPCR) analysis of mRNA expression, total RNA was first isolated
from cells using Trizol reagent. Reverse transcription of RNA to
cDNA and analysis of relative mRNA levels by RT-qPCR were
done as described [27,29]. Sequences of the qPCR primers are
available upon request or have been previously described [29].
SRA Role in Adipocytes
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Luciferase Reporter Gene Assay
3T3-L1 preadipocytes were cotransfected with pIRP-GLuc or
pGluc-Basic (100 ng) and either pSCT or pSCT-SRA, pSCT-
SRAP or pSCT-SRAP silent mutant plasmids for 48 hr using
Lipofectamine Plus Reagent (Invitrogen) in 24 well plates, and
luciferase activity was measured using a BioLux Gaussia Lucifer-
ase Assay Kit (New England Biolabs, Inc.).
Statistical Analysis
Results are presented as the mean6SD. When comparing two
groups, significance was determined using Student’s t test. When
more than two groups were compared, an analysis of variance
(ANOVA) was followed by Scheffe’s test, and the significance is
indicated as *p,0.05; **p,0.01, and ***p,0.001.
Results
SRA Overexpression Enhances Adipogenesis in ST2
Adipocyte Precursors in an Insulin-dependent Manner
Our previous studies showed that overexpression of SRA
enhances adipogenesis in ST2 precursors induced with full
hormonal cocktail (MDI) but has little effect on spontaneous
adipogenesis in the absence of MDI [29]. Therefore, we
hypothesized that SRA influences adipogenesis by regulating
pathways targeted by MDI. To address this hypothesis, ST2
adipocyte precursors stably containing either an empty control
vector pMSCV (Control) or pMSCV-SRA (SRA) were estab-
lished, in which SRA RNA was overexpressed ,140 fold
(Figure 1A) but without SRAP overexpression (Figure 1B). ST2
Control or ST2 SRA overexpressing adipocyte precursors were
induced to differentiate with full MDI or with single- or double-
combinations of each component. Effects on adipogenesis were
Figure 1. SRA overexpression enhances adipogenesis in ST2 adipocyte precursors in an insulin-dependent manner. ST2 cells were
retrovirally transduced with an SRA expression vector (pMSCV-SRA, denoted as SRA) or empty vector control (pMSCV, denoted as Control). A, Stable
overexpression of SRA were confirmed by RT-qPCR using human SRA primers. Transcript expression was normalized to Ppia (cyclophilin A) and is
presented as mean 6 S.D. relative to the SRA expression determined in control cells set at 1. B, Immunoblot using an SRAP specific antibody
indicated similar endogenous SRA protein (SRAP) expression in Control and SRA overexpressing ST2 cells. The same membrane was re-probed with
anti-b-actin as a loading control. C, Cells were induced to differentiate into adipocytes by treatment with fetal calf serum (FCS), insulin (Ins),
dexamethasone (Dex), methylisobutylxanthine (IBMX), or the indicated combinations. Micrographs of cells at day 4 post-induction indicate lipid
accumulation. D, Expression of Fabp4, Pparg, Cebpa, or Adipoq (adiponectin) was determined by RT-qPCR at the end of differentiation at day 4.
Transcript expression was normalized to Ppia (cyclophilin A) and is presented as mean6 S.D. relative to expression in FCS-induced control cells set at
1. Statistical significance was evaluated with Student’s t test: *p,0.05, **p,0.01 and ***p,0.001. Results are representative of three independent
experiments.
doi:10.1371/journal.pone.0095416.g001
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then evaluated at day 4 post-induction by assessing lipid droplet
accumulation and expression of adipocyte marker genes. In
agreement with a previous study [10], we found that lipid droplet
formation was strongly induced with cocktails containing insulin
(Figure 1C), although some lipid droplets also were apparent in
SRA-expressing cells induced with Dex plus IBMX. Expression of
the adipocyte marker Fabp4 (also known as aP2) also was most
prominent in SRA over-expressing cells with cocktails containing
insulin (Figure 1D), although the expression of other adipocyte
markers (Pparg, Cebpa, Adipoq) was not as strictly dependent on
insulin. These observations suggest that SRA enhances ST2
adipogenesis at least in part by sensitizing ST2 precursors to the
pro-adipogenic effects of insulin.
Thiazolidinediones (TZDs) are adipogenic ligands for PPARc,
and as such TZDs induce many adipocyte PPARc target genes
[36,37]. Given that SRA can function as an RNA coactivator for
PPARc [29], we asked whether insulin also is required for the pro-
adipogenic effect of SRA even in the presence of a TZD (MDT vs.
MDIT). Indeed, MDT without insulin produces very little lipid
droplet accumulation, even with SRA overexpression (Figure 2A).
At the gene expression level, MDIT induces the adipocyte markers
Fabp4, Pparg, Cebpa and Adipoq more strongly than does MDT.
However, the ability of SRA to induce these genes is similar with
or without insulin, with the possible exception of Pparg (Figure 2B).
SRA Regulates p38/JNK Activity during Early
Preadipocyte Differentiation
We next investigated how SRA expression affects signals
downstream of insulin. Insulin influences adipocyte differentiation
through regulation of MAPKs, including ERK1/2 (p44/p42), p38
and c-Jun amino-terminal kinase (JNK), each of which can
regulate adipogenesis [12,38,39,40,41]. We previously showed that
SRA is expressed at low levels in ST2 precursors and high levels in
3T3-L1 preadipocytes, and therefore we have used SRA
overexpression in ST2 precursors and knockdown in 3T3-L1
preadipocytes to assess the potential roles of SRA in adipocyte
biology [29]. We continued to use these two model systems in the
present investigations. SRA overexpression in ST2 precursors
(Figure 3A) or knockdown in 3T3-L1 preadipocytes (knockdown of
both SRA and SRAP are confirmed in Figure 3B) did not affect
phosphorylation of p44/42 (Figure 3A; data not shown). In
contrast, stable SRA overexpression in ST2 precursors was
associated with marked inhibition of p38 phosphorylation
(Figure 3A). This suggests that SRA may enhance ST2 adipogen-
esis by suppressing p38 activation, because p38 activity likely
inhibits adipogenesis [38]. However, stable knockdown of SRA did
not affect p38 activation in 3T3-L1 preadipocytes (Figure 3C),
even though adipogenesis is impaired in these cells [29].
In general, over-expression of SRA in ST2 cells inhibited, and
knockdown of SRA in 3T3-L1 cells stimulated, JNK phosphor-
ylation, although the specific details differed in the two cell lines
(Figure 3). In ST2 cells, MDI increased the quantity of two low
molecular weight (,46 kDa) phosphoJNK (P-JNK) isoforms and
SRA over-expression inhibited this phosphorylation (Figure 3A). A
larger (,54 kDa) P-JNK isoform was essentially unaffected by
MDI and SRA over-expression. 3T3-L1 cells differed in that SRA
knockdown did not affect phosphorylation of the smaller JNK
isoforms, but it did induce phosphorylation of the larger JNK
isoform (Figure 3C).
There are three genes, each with alternative transcripts, that
encode JNK proteins, the end result of which is 10 JNK protein
isoforms whose molecular weights are approximately 46 kDa
(JNK1a1, JNK1b1, JNK2a1, JNK2b1 and JNK3a1) or 54 kDa
(JNK1a2, JNK1b2, JNK2a2, JNK2b2 and JNK3a2) [42,43].
Using antibodies specific for JNK1, JNK2 or JNK3, we found that
all 3 are expressed in both ST2 and 3T3-L1 cells, although JNK3
has the weakest signal (Figures 3A and 3C). JNK1 shows bands
representing both its p46 and p54 isoforms (a1/b1 and a2/b2,
Figure 2. Differentiation of ST2 cells into adipocytes in the
presence of a PPARc agonist is insulin- and SRA-dependent.
ST2 cells were transduced with either SRA expression vector (pMSCV-
SRA) or empty control vector (pMSCV) and induced to differentiate by
treatment with methylisobutylxanthine (M), dexamethasone (D) and
troglitazone (T), without or with insulin (I). A, Oil Red O staining to
identify triglyceride droplets. B, Expression of Fabp4, Pparg, Cebpa, and
Adipoq (adiponectin) determined by RT-qPCR and normalized to Ppia
(cyclophilin A). Results are mean 6 S.D. relative to MDT-induced
controls. Statistical significance was evaluated with Student’s t test, or
ANOVA followed by Scheffe’s test: *p,0.05, **p,0.01 and ***p,0.001.
Results are representative of three independent experiments.
doi:10.1371/journal.pone.0095416.g002
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respectively), whereas only the larger isoform is detected for JNKs
2 and 3.
To facilitate direct comparisons of these isoforms, we loaded
one sample from ST2 cells into multiple lanes of one gel, and
similarly for 3T3-L1 cells. After Western transfer, the membrane
was cut and each lane was probed with an antibody to either P-
JNK, JNK (total JNK), JNK1, JNK2 or JNK3. The results are
shown in Figure 3D, which confirms that only the larger isoforms
of JNKs 2 and 3 are present, as noted above. The JNK antibody
also detects a low molecular weight band not detected by the
Figure 3. SRA regulates p38/JNK activity during early preadipocyte differentiation. A, Control or SRA-overexpressing ST2 cells were grown
to confluence and induced to differentiate with MDI. Cell lysates were obtained at the indicated times post-MDI induction. Phosphorylation and total
protein expression of p38, p44/42 and JNK was assessed by immunoblotting using specific antibodies, as indicated. B, 3T3-L1 preadipocytes with
stable knockdown of SRA were generated by retroviral infection with an shRNA against SRA (shSRA); a scrambled shRNA was used to generate
control preadipocytes (shControl). Left panel, stable knockdown of endogenous SRA RNA in 3T3-L1 preadipocytes was determined by RT-qPCR using
mouse SRA primers. Transcript expression was normalized to Ppia (cyclophilin A) and is presented as mean 6 S.D. relative to expression in shControl
cells set at 1. Right panel, immunoblot using an SRAP specific antibody confirmed the effective knockdown of endogenous SRA protein (SRAP) in
shSRA 3T3-L1 preadipocytes. Reprobing with anti-b-actin served as a loading control. Bands were quantified from immunoblot digital images using
Bio-Rad Quantity One software, and the relative results are presented below each immunoblot image. C, shSRA and shControl 3T3-L1 preadipocytes
were induced with MDI and protein phosphorylation assessed as described for cells in Figure 3A. Bands labeled a and b in the P-JNK immunoblot, and
a1 and b1 in the total JNK immunoblot, correspond to the p54 and p46 kDa species and were quantified as stated above. Results in A, B and C are
representative of three independent experiments. D, For ST2 cells, the sample +10 minutes MDI minus SRA was loaded into multiple lanes of one gel
and immunoblotted. The membrane was cut so that each lane could be probed individually with an antibody to either phosphoJNK (P-JNK), total JNK
(JNK), JNK1, JNK2 or JNK3. The lanes were reassembled to capture the digital image shown. A similar procedure was used for 3T3-L1 cells +10 minutes
MDI +shSRA.
doi:10.1371/journal.pone.0095416.g003
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JNK1, 2 or 3-specific antibodies. This band is unaffected by any
experimental manipulations, and whether it represents a JNK or a
cross-reacting protein is not known. The largest P-JNK band
corresponds to the larger JNK isoform and hence could be due to
phosphorylation of the larger isoforms of JNKs 1, 2 and/or 3. At
the position of the smaller JNK1 isoform, the P-JNK lane shows a
doublet, which has been previously described [44,45].
Thus, although there are JNK isoform differences in the
response to SRA over-expression in ST2 cells and SRA
knockdown in 3T3-L1 cells, the overall pattern is one in which
SRA inhibits JNK phosphorylation. Given that JNK activation
(phosphorylation) inhibits insulin action in cultured cells [46],
these observations support the possibility that SRA promotes
adipogenesis and insulin sensitivity in part via regulation of JNK.
Knockdown of SRA in 3T3-L1 Adipocytes is Associated
with Downregulation of IR Protein and mRNA, and
Decreased Downstream Insulin Signaling Pathway
Phosphorylation
We have previously shown that the impaired insulin-stimulated
glucose uptake in SRA knockdown 3T3-L1 adipocytes is
associated with decreased insulin-stimulated Akt phosphorylation
[29]. Here we further examine how SRA knockdown modulates
insulin signaling. ShControl or shSRA knockdown 3T3-L1
preadipocytes were differentiated with MDIT and then serum-
starved and treated with or without insulin. SRA/SRAP
knockdown to ,20% of control was confirmed in Figure 3B and
previously [29]. The phosphorylation state of downstream targets
was assessed by immunoblotting (Figure 4). We found that SRA
knockdown decreased autophosphorylation of key tyrosine sites
(pY972, 1328, 1345 and 1361) of IRb, as well as downstream
tyrosine phosphorylation of IRS-1 at pY612 and 941 and
phosphorylation of Akt. In addition, compared to shControl
adipocytes, IRb protein content and mRNA expression in shSRA
adipocytes was decreased by up to 50%, and protein expression of
the IR precursor was similarly decreased (Figure 4, A & B).
We next investigated if lentiviral SRA knockdown in mature
3T3-L1 adipocytes also affects IRb protein levels and downstream
phosphorylation events. 3T3-L1 adipocytes already differentiated
to day 6 post-induction were infected with lentiviruses expressing
shRNA against SRA or a GFP control. SRA and SRAP effective
knockdown was confirmed in Figure 5A. As found above for SRA
knockdown prior to adipocyte differentiation, SRA knockdown of
already-differentiated 3T3-L1 adipocytes was associated with
decreased content of IRb protein and RNA under both basal
and insulin-stimulated conditions (Figure 5B, lanes 2 vs 1, and 4 vs
3). In addition, knockdown of SRA decreased insulin-stimulated
tyrosine autophosphorylation of IRb at pY972 and pY1328
(Figure 5B). Insulin-stimulated IRS-1 tyrosine phosphorylation
also was reduced in SRA knockdown adipocytes, as was
phosphorylation of Akt (Figure 5C and 5D).
SRA but not SRAP Transient Expression Upregulates the
IR Gene Promoter
The negative effect of SRA knockdown on IR protein content
likely occurs at a transcriptional level, since SRA knockdown also
decreased IR mRNA expression to a similar extent (Figure 4B &
5B). To test this hypothesis, we compared the effects of SRA RNA,
SRAP and SRA/SRAP with various mutations on transcription
driven by the IR gene promoter in a reporter assay. As shown in
Figure 6A, these plasmids include pSCT-SRA (denoted as SRA
Only), which expresses the human SRA RNA core sequence but
not SRAP [24]; pSCT-hSRAP (denoted as SRA-WT), which
Figure 4. Depletion of SRA decreases autophosphorylation of
insulin receptor b, tyrosine phosphorylation of IRS-1 and
expression of IRb. 3T3-L1 preadipocytes with stable knockdown of
SRA (shSRA) or with shControl infection were induced to differentiate
with MDIT. At day 11 post-induction, adipocytes were serum-starved for
12 h followed by treatment with or without insulin (10 nM) for the
indicated durations. A, Total cell lysates were subjected to immuno-
blotting (IB) with antibodies against the indicated phospho-proteins or
total IRb, IRS-1, or Akt; b-actin was used as a loading control. Expression
of pY612 and pY941-IRS-1, IRS-1, P-Akt, Akt, IRb and b-actin was
quantified from immunoblot digital images using Bio-Rad Quantity One
software. As indicated below the IRb blotting, expression of P-Akt and
IRb protein was normalized to expression of either Akt or b-actin and
the signal of each band was compared to that for control cells as
indicated (for which the level of expression was set at 1). B, Gene
expression of IR mRNA at each condition was analyzed by RT-qPCR and
was normalized to the expression of b-actin.
doi:10.1371/journal.pone.0095416.g004
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expresses both full length SRA mRNA and SRAP; pSCT-hSRAP-
RNA (denoted SRA-RNA), in which pSCT-hSRAP was mutated
at codon 13 (ATG to TGA) thus preventing expression of SRAP
while causing only this 3 nucleotide change in the sequence of
expressed SRA RNA; and pSCT-SRAP-SDM1/7 and pSCT-
SRA-RNA-SDM1/7 that contain silent mutations in SRA stem
loops 1 and 7 as described previously [34]. These mutations
disrupt the structures of stem loops 1 and 7, which are critical for
SRA function, without altering the protein sequence of the
encoded SRAP. Cotransfection of the IR promoter – luciferase
reporter (pIRP-Gluc) or pGluc-Basic lacking the IR promoter
sequence with SRA RNA, SRAP or the mutated constructs
described above indicated that SRA Only demonstrates enhance-
ment of pIRP-Gluc reporter activity (Figure 6B, bar 2 vs. 1), but
SRA-WT that expresses both SRA mRNA and SRAP does not
(bar 3). As expected, SRA-RNA (bar 4) that expresses SRA mRNA
but has its 13th codon mutated to a stop signal has comparable
coactivation to SRA Only. SRAP-SDM1/7 that expresses a stem
loop-disrupted SRA but wild type SRAP shows further decreasing
activity compared to SRA only and SRA-WT (bar 5 vs. 2 and 3).
In addition, SRA-RNA-SDM1/7 no longer activates transcription
(bar 6 vs. 4). In addition, neither SRA Only nor SRA-RNA
coactivates the reporter lacking the IR promoter sequence (bars 10
& 11 vs. 9), indicating SRA’s activity is specific for the IR
promoter. In agreement with previous findings that SRAP may
inhibit its own RNA function [47], our data support that SRAP
may inhibit its own mRNA’s coactivation (bar 3 vs. 4). This
conclusion was further substantiated in that SRA-WT (expressing
both full-length SRAP and SRA mRNA) and SRAP-SDM1/7
(expressing SRAP with impaired RNA function) inhibit the
coactivation of SRA Only (bars 7 & 8 vs. 2 & 4). Appropriate
expression of the various SRA RNA and SRAP constructs was
confirmed in Figures 6 C and D.
Discussion
SRA has been characterized as a long non-coding RNA that
enhances the transcriptional activity of steroid receptors [24], non-
steroid nuclear receptors and other transcription factors
[25,26,27,28]. By alternative splicing, the SRA1 gene also encodes
Figure 5. Knockdown of SRA in 3T3-L1 mature adipocytes is
associated with downregulation of IR protein content and
downstream insulin signaling pathway phosphorylation
events. 3T3-L1 adipocytes at day 6 post-induction with MDI were
infected with lentivirus expressing control (pLentiLox3.7-GFP) or SRA
knockdown shRNA (pLentiLox3.7-shRNA). At day 11 post-MDI, adipo-
cytes were starved for 12 h and treated without or with 10 nM insulin
for 20 min. A, To confirm effective knockdown of endogenous SRA, an
immunoblot was probed with an anti-SRAP specific antibody, and RT-
qPCR was performed for SRA expression that was normalized to b-actin.
B, Gene expression of IR at each condition analyzed by RT-qPCR and
was normalized to the expression of b-actin. Immunoblots were
subsequently performed on cell lysates from control or SRA -depleted
adipocytes using antibodies as indicated. C, Similar to Figure 5A, serum-
starved day 11 adipocytes were treated with or without insulin, cell
lysates were first applied to immunoprecipitation for anti-IRS-1,
followed by immunoblotting for anti-tyrosine (4G10). D, Immunoblots
were performed for cell lysates indicated in A using Akt phospho- or
total- antibodies. A–D, Quantification of each band was performed
using a Bio-Rad Fluor-S MAX MultiImager. For IRb, b-actin, IRS-1 and Akt,
the signal of each band was compared to that for control cells without
insulin treatment (for which the level of expression was set at 1). For
tyrosine phosphorylation of IRb and IRS-1 (pY-) and phospho-Akt, band
intensity was set at 1 for insulin-treated control cells. These results are
representative of three independent experiments.
doi:10.1371/journal.pone.0095416.g005
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an SRAP protein [31,33]. SRA RNA appears to have diverse
biological functions, such as in mammary gland development [48]
and muscle differentiation [25], although the lack of a knockout
mouse has impeded analysis of the function of SRA in vivo. The
function of SRAP has been even more difficult to discern, in part
because SRAP expression requires expression of the RNA, and in
part because SRA and SRAP have been shown to exist together in
a ribonucleoprotein complex [47].
We previously showed that SRA promotes adipogenesis and
stimulates insulin-stimulated glucose uptake and Akt activation in
adipocytes [29]. However, the mechanisms underlying these
effects of SRA are not well understood. In the present study we
found that SRA overexpression in ST2 adipocyte precursors
significantly promotes adipogenesis, especially upon induction
with hormonal cocktails that include insulin (Figure 1). This led us
to investigate potential effects of SRA on insulin signaling. A
combination of overexpression and knockdown studies indicate
that SRA but not SRAP induces gene expression driven by the IR
promoter. This results in elevated IR mRNA and protein
expression, with consequent increases in insulin-stimulated phos-
phorylation of IRS-1 and Akt (Figure 4–5). Expression of the IR
gene is regulated by numerous transcription factors, including C/
EBPa/b, glucocorticoid receptor, Sp1, NF-1 and others. We
speculate that SRA coactivates one or more of these factors to
induce IR expression. In fact, SRA is known to coactivate the
glucocorticoid receptor [24], although it has been reported not to
coactivate Sp1 [24] or C/EBPa [29].
Recent studies suggest that active p38 MAPK inhibits
adipogenesis [38]. Therefore, our observation of decreased p38
MAPK activation (Figure 3A) could explain the enhanced
adipogenesis in SRA-overexpressing ST2 precursors. However,
stable knockdown of SRA did not affect p38 activation in 3T3-L1
adipocytes (Figure 3C), even though adipogenesis is impaired in
these cells [29]. Therefore, the contribution of altered p38 activity
to the adipogenic effects of SRA may depend on the cell type or
other factors.
In addition, we demonstrate that SRA overexpression markedly
inhibits, while depletion increases, phosphorylation of certain JNK
species (Figure 3). Since the absence of JNK1 enhances insulin
receptor signaling [40], the inhibition of JNK activity by SRA may
Figure 6. SRA not SRAP transient expression upregulates IR
transcription. A, Schematic presentation of the SRA1 gene and
expression constructs used in the reporter assay. The human SRA1 gene
contains five exons as indicated by the grey boxes. ‘‘SRA Only’’ contains
the human SRA core sequences from exons 2–5 that only express SRA
RNA. SRA-WT is the full-length human Sra1 cDNA that expresses both
SRAP and SRA mRNA. SRA-RNA is the SRA-WT cDNA in which codon 13
was mutated from ATG to TGA, so that SRAP is not expressed. SRAP-
SDM1/7 and SRA-RNA-SDM1/7 are plasmids that are based on the SRA-
WT and SRA-RNA constructs with introduction of silent nucleotide
mutations in the stem loops 1 and 7, which disrupt the RNA stem loop
structures (and hence impair coactivation by SRA [34]) without
changing the amino acid sequence of the encoded SRAP. B, SRA
upregulates IR transcription in 3T3-L1 cells. 3T3-L1 preadipocytes were
cotransfected with either empty vector (pSCT, 500 ng), pSCT-SRA Only
(500 ng), or other SRA/SRAP constructs (500 ng) as indicated and IR
promoter (pIRP-Gluc, 100 ng in lanes 1–8) or pGluc-Basic (lanes 9–11)
driven luciferase expressing plasmids. Forty-eight hours post-transfec-
tion, luciferase activity was measured. Data were expressed as fold
change after normalization with the total cell protein content of each
well. These results are representative of five independent experiments.
Error bars indicate the standard deviation. The results of statistical
analyses by ANOVA followed Scheffe’s test, comparing bar 1 with bars
2–8, and bar 9 with bars 10–11 and with bars 2 and 4, are shown in the
figure (*, p,0.05). C, Confirmation of SRA overexpresion in the transient
transfection in B by RT-qPCR, using human SRA primers and normalized
to Ppia (cyclophilin A). The data are presented as the mean 6 S.D.
relative to the SRA expression in pSCT cells set at 1. D, Immunoblot
using anti-SRAP indicating SRAP expression in the transient transfection
in B (endogenous SRAP expression in lanes 1, 2, 4, 6, and 9–11 was
visible only with a longer exposure). Immunoblotting with anti-b-actin
served as a loading control.
doi:10.1371/journal.pone.0095416.g006
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further activate insulin signaling and promote adipocyte differen-
tiation. By alternative processing of RNA transcripts, the genes
encoding JNK1, JNK2 and JNK3 produce 10 protein isoforms of
approximately 46 and 54 kDa [42]. We noted that SRA
overexpression in ST2 cells only inhibits the phosphorylation of
p46 JNK (which represents JNK1), while SRA knockdown in 3T3-
L1 preadipocytes primarily upregulates phosphorylation of p54
JNK (which may represent JNKs 1, 2 and/or 3) (Figure 3A, C).
There are several potential explanations for these differences. The
shSRA depletes both SRA (RNA) and SRAP (protein), whereas
the SRA over-expression vector does not produce SRAP. The
function of SRAP is unknown, but it could potentially play a role
in the regulation of JNK phosphorylation. Another possibility is
that p46 JNK phosphorylation may already be maximally induced
by MDI in 3T3-L1 cells, so that loss of SRA cannot induce it
further. Similarly, ST2 cells may contain enough endogenous SRA
to maximally inhibit p54 JNK phosphorylation such that over-
expression has no further effect, whereas the inhibition of p46 JNK
phosphorylation may require a higher level of SRA. Alternatively,
there may be cell-specific differences in the expression or
availability of upstream MAPK kinases and associated proteins
that are recruited to the SRA ribonucleoprotein complex.
SRA is highly expressed in breast and prostate cancer cells
[31,49]. Thus, the ability of SRA to induce IR protein expression
and increase downstream phosphorylations of IRS-1 and Akt in
response to insulin may occur in these and possibly other cancers.
In these settings SRA/SRAP could contribute to Akt-stimulated
cancer cell growth.
In summary, the present study reveals that SRA plays an
intrinsic role in the regulation of adipocyte differentiation and
insulin signaling, at least in part by inhibiting phosphorylation of
JNK and p38 MAPK, increasing IR transcription, maintaining
IRb protein levels and enhancing downstream signaling pathways
through IRS-1 and Akt.
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